Inside Innovation

Boston-based biotech startup GentiBio has secured licensing deals with Seattle Children’s Research Institute and Benaroya Research Institute at Virginia Mason. The technology from both Seattle-based

Adaptive Biotechnologies is continuing with its plans to move into a 100,000-square-foot headquarters. The new facility, slated to open next year, will allow Adaptive to

Cellular therapy company Lyell Immunopharma is investing $50 million in a new 70,000 square foot manufacturing facility located in Bothell, Washington. This investment will support

CorneaGen, a Seattle-based provider of corneal transplant tissue, committed to donating $100,000 to help fund corneal transplant surgeries for underprivileged people of color in need

The University of Washington and Seattle-based HDT Bio Corp. announced the development of a promising COVID-19 vaccine candidate that uses a cutting-edge approach. Based on

Seattle-based biotech research startup A-Alpha Bio has received an $800,000 grant from the Bill & Melinda Gates Foundation that will support drug research for treating